FF
Insider selling
Fairmount Funds Management Llc sold $300M of Oruka Therapeutics, Inc. (ORKA) stock
Fairmount Funds Management Llc, Dir, 10% of Oruka Therapeutics, Inc. (ORKA), sold 3,553,410 shares of ORKA stock worth $300M, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 1, 2026, 1 day before it was made public.
ORKA has moved +0.1% since the trade date, from $93.29 to $93.38 (Sep 21, 2026 close).
- Traded
- Jul 1, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 1 day
- Price since
- +0.1%
- Role
- Dir, 10%
- Source
- SEC Form 4
More ORKA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.